Dear Mladen,
Thank you very much for your answer. Perhaps should I have formulated my
question more precisely. I am sure you are aware of the “call for
innovative technologies that address global health concerns” from the
WHO. In these regards I was wondering what would happen in the following
scenario: let’s assume some company or team develops an appropriate
version of a pulse-oxymeter designed for the resource-constrained
markets. It is very likely that it will include some design solutions
that might have been patented by existing for-profit companies, active
worldwide but focused on developed markets (some companies use a “carpet
bombing” IP strategy where they patent everything on and around their
core technology). I am wondering if we will see similar developments as
with drugs. Perhaps will we just have to wait and see…
I hope this makes sense.
Tanks
Cordially
Klaus Schonenberger
